Recent #Diabetes news in the semiconductor industry

2 months ago

➀ Researchers developed a green method to synthesize silver nanoparticles from Martynia annua roots, avoiding toxic by-products of traditional production;

➁ The nanoparticles exhibited strong antioxidant activity and inhibited α-amylase, showing potential for managing diabetes by reducing blood glucose spikes;

➂ Characterization via UV/Vis, FTIR, and SEM confirmed stable, uniformly sized nanoparticles (64 nm), highlighting their biomedical promise and eco-friendly synthesis.

Diabetes
11 months ago
1. Novo Nordisk remains a sell due to increased competition and regulatory risks despite its leadership in the diabetes and weight-loss markets. 2. Hims & Hers anticipates selling a generic version of NVO's liraglutide, threatening sales as soon as next year. 3. Intense competition from Viking Therapeutics and Amgen may result in a new best-in-class GLP-1 drug, further threatening Novo's market position.
Diabetes
over 1 year ago
1. The National Diabetes Strategy (NDS) has been awaiting implementation for 4 years since its inception in 2020; 2. The Deutsche Diabetes Gesellschaft (DDG) and diabetesDE call for the immediate reintroduction of the NDS into the national health agenda; 3. The Bundesgesundheitsministerium (BMG) is criticized for focusing on individual measures rather than a holistic approach to combat diabetes and related diseases.
DiabetesHealth PolicyPrevention